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PURPOSE: The aim of this study was to evaluate associations between pre- and postdiagnosis 
physical activity and survival in survivors of endometrial cancer by physical activity domain, 
intensity, dose (metabolic-equivalent task [MET]-hours/week/year), and change from pre- to 
postdiagnosis. METHODS: We conducted a prospective cohort study in Alberta, Canada, of 
425 women who were diagnosed with histologically confirmed invasive endometrial cancer 
between 2002 and 2006 and observed to 2019. The interviewer-administered Lifetime Total 
Physical Activity Questionnaire recorded prediagnosis (assessed at a median of 4.4 months after 
diagnosis) and postdiagnosis physical activity (assessed at a median of 3.4 years after diagnosis). 
Associations between physical activity and overall and disease-free survival were assessed using 
Cox proportional hazards models adjusted for age, stage, grade, treatments, body mass index, 
menopausal status, hormone therapy use, family history of cancer, and comorbidities. 
RESULTS: After a median follow-up of 14.5 years, there were 60 deaths, including 18 
endometrial cancer deaths, and 80 disease-free survival events. Higher prediagnosis recreational 
physical activity was statistically significantly associated with improved disease-free survival (> 
14 v ≤ 8 MET-hours/week/year; hazard ratio [HR], 0.54; 95% CI, 0.30 to 0.96; Ptrend = .04), but 
not overall survival (HR, 0.56; 95% CI, 0.29 to 1.07; Ptrend = .06). Higher postdiagnosis 
recreational physical activity (> 13 v ≤ 5 MET-hours/week/year) was strongly associated with 
both improved disease-free survival (HR, 0.33; 95% CI, 0.17 to 0.64; Ptrend = .001) and overall 
survival (HR, 0.33; 95% CI, 0.15 to 0.75; Ptrend = .007). Participants who maintained high 
recreational physical activity levels from pre- to postdiagnosis also had improved disease-free 
survival (HR, 0.35; 95% CI, 0.18 to 0.69) and overall survival (HR, 0.43; 95% CI, 0.20 to 0.94) 
compared with those who maintained low physical activity levels. CONCLUSION: 
Recreational physical activity, especially postdiagnosis, is associated with improved survival in 
survivors of endometrial cancer. 
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abstract
PURPOSE The aim of this study was to evaluate associations between pre- and postdiagnosis physical activity and
survival in survivors of endometrial cancer by physical activity domain, intensity, dose (metabolic-equivalent task
[MET]-hours/week/year), and change from pre- to postdiagnosis.
METHODSWe conducted a prospective cohort study in Alberta, Canada, of 425 women who were diagnosed with
histologically confirmed invasive endometrial cancer between 2002 and 2006 and observed to 2019. The
interviewer-administered Lifetime Total Physical Activity Questionnaire recorded prediagnosis (assessed at
a median of 4.4 months after diagnosis) and postdiagnosis physical activity (assessed at a median of 3.4 years
after diagnosis). Associations between physical activity and overall and disease-free survival were assessed
using Cox proportional hazards models adjusted for age, stage, grade, treatments, body mass index, meno-
pausal status, hormone therapy use, family history of cancer, and comorbidities.
RESULTS After a median follow-up of 14.5 years, there were 60 deaths, including 18 endometrial cancer deaths,
and 80 disease-free survival events. Higher prediagnosis recreational physical activity was statistically signif-
icantly associated with improved disease-free survival (. 14 v # 8 MET-hours/week/year; hazard ratio [HR],
0.54; 95% CI, 0.30 to 0.96; Ptrend5 .04), but not overall survival (HR, 0.56; 95% CI, 0.29 to 1.07; Ptrend5 .06).
Higher postdiagnosis recreational physical activity (. 13 v # 5 MET-hours/week/year) was strongly associated
with both improved disease-free survival (HR, 0.33; 95% CI, 0.17 to 0.64; Ptrend 5 .001) and overall survival
(HR, 0.33; 95% CI, 0.15 to 0.75; Ptrend 5 .007). Participants who maintained high recreational physical activity
levels from pre- to postdiagnosis also had improved disease-free survival (HR, 0.35; 95% CI, 0.18 to 0.69) and
overall survival (HR, 0.43; 95% CI, 0.20 to 0.94) compared with those who maintained low physical activity
levels.
CONCLUSION Recreational physical activity, especially postdiagnosis, is associated with improved survival in
survivors of endometrial cancer.
J Clin Oncol 38:4107-4117. © 2020 by American Society of Clinical Oncology
Creative Commons Attribution Non-Commercial No Derivatives 4.0 License
INTRODUCTION
Globally, endometrial cancer is the sixth most common
cancer among women.1 In 2018, endometrial cancer
was diagnosed in an estimated 380,000 women and
resulted in approximately 90,000 deaths.1 In Canada,
the 5-year survival rate for endometrial cancer is 83%,
but mortality rates have worsened by 2% since 1984,
making it one of few cancers for which mortality rates
are rising.2 Obesity and diabetes are strong risk factors
for endometrial cancer and survivors are thus also at
increased risk of dying from these conditions and
related diseases, such as cardiovascular disease3,4;
therefore, interventions in this population that improve
survival are needed.5,6 Whereas physical inactivity is
an established risk factor for endometrial cancer in-
cidence, independent of obesity, few studies have
examined the associations between physical activity
and endometrial cancer survival.7-10 To date, results
are inconclusive and limited in scope. Specifically, no
studies have examined associations between physical
activity and endometrial cancer survival by domain or
intensity of activity, nor by change from pre- to post-
diagnosis physical activity levels.
The primary objective of this study was to assess the
strength of the associations between pre- and post-
diagnosis physical activity by domain (total, recreational,
household, and occupational), dose, frequency, intensity
and duration for overall and disease-free survival. Our
secondary objective was to assess the strength of the
association between changes from pre- to postdiagnosis
physical activity with survival outcomes.We hypothesized
that women who accumulated greater amounts of pre-
and postdiagnosis physical activity would have better
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METHODS
Setting and Participants
Participants were 425 women residing in Alberta, Canada,
with histologically confirmed invasive endometrial cancer
who participated in a previous case-control study.11 Cases
were diagnosed from 2002 to 2006, identified through the
Alberta Cancer Registry (ACR), and then observed for survival
outcomes. Eligibility criteria were age 30 to 80 years, English
speaking, able to complete an in-person interview, and no
previous cancer diagnosis, with the exception of non-
melanoma skin cancer. Of the 549 patients in the case-control
study, eight were ineligible because of misclassification
(n5 1) or missing data (n5 7), 51 died before follow-up data
collection, 30 declined participation, and 35 were lost to
follow-up, leaving 425 who participated in the follow-up
assessments (77%) and who were analyzed in this study11
(Appendix Fig A1, online only). Ethics approval for follow-up
and medical record review were received from the ethics
boards of the former Alberta Cancer Board, the University of
Calgary, and theUniversity of Alberta. All participants provided
written informed consent for the cohort study.
Data Collection
Physical activity assessment. We measured prediagnosis
physical activity participation using the Lifetime Total
Physical Activity Questionnaire, previously tested for re-
liability.12 Trained interviewers used cognitive interviewing
methods and a recall calendar to assess the frequency,
duration, and intensity of occupational, household, and
recreational physical activities from childhood until di-
agnosis.13 Baseline assessment occurred at a median of
4.4 months (interquartile range, 3.4-5.7 months) after di-
agnosis. During in-person follow-up interviews conducted
between 2006 and 2011, postdiagnosis physical activity
levels were measured for each participant using a modified
Lifetime Total Physical Activity Questionnaire that captured
their physical activity since diagnosis. These follow-up as-
sessments occurred at a median of 3.4 years (interquartile
range, 3.4-5.7 years) after diagnosis.
Covariates. At baseline assessment, participants reported
their demographic characteristics (age at diagnosis, highest
education, marital status, race), comorbidities (summarized
as a baseline comorbidity score of none, 1, or $ 2), men-
strual and reproductive history (age at menarche, number
of pregnancies$ 20 weeks, age at menopause, menopausal
status), hormone use history, and first degree family history of
uterine or colorectal cancer. Alcohol intake (gram/day/year),
smoking habits, diet, and participant height, weight, and waist
and hip circumferences were captured at baseline and follow-
up. Total caloric intake (kcal/day) was measured using the
self-administered Canadian Diet History Questionnaire.14
Anthropometric measurements were taken in triplicate and
averaged using standardized methods and calibrated scales.
Postdiagnosis comorbid conditions were determined using
the Charlson Comorbidity Index.15
Chart abstractions and vital status. Between 2006 and
2019, data on staging, treatment, vital status, new primary
cancers, and recurrences or progressions were abstracted
from medical charts via ACR and Vital Statistics Alberta by
health record technicians with no access to the physical
activity data. Staging followed the American Joint Com-
mittee on Cancer guidelines.16 Cancer grade was previously
determined from tissue samples obtained at hysterectomy
and classified by a study pathologist.17 Participants were
observed from cancer diagnosis until death or until the final
vital status check on March 20, 2019, whichever occurred
first. Cause of death for all cases was ascertained by ACR
through linkages with Statistics Canada.
Statistical analyses. We used the Compendium of Physical
Activities to assign metabolic equivalent task (MET) values
to each self-reported physical activity.18 OneMET is defined
CONTEXT
Key Objective
Limited research exists on whether physical activity is associated with survival after an endometrial cancer diagnosis. To our
knowledge, this study was the first to examine how different domains and intensities of pre- and postdiagnosis physical
activity, as well as changes in physical activity from pre- to postdiagnosis, are associated with survival outcomes.
Knowledge Generated
Higher recreational physical activity, especially when done postdiagnosis, was strongly associated with improved overall and
disease-free survival after endometrial cancer. The strongest associations with survival were experienced by women who
maintained high levels of recreational physical activity throughout their prediagnosis lifetime and into their endometrial
cancer survivorship.
Relevance
Staying physically active or becoming physically active after an endometrial cancer diagnosis may improve survival out-
comes. Clinicians should recommend physical activity to patients with newly diagnosed endometrial cancer and survivors
to improve health-related fitness, quality of life, and possibly even survival.
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as 1 kcal/kg per hour and is roughly equivalent to the
energy cost of sitting quietly. For each individual, total
physical activity was estimated as the sum of nonsedentary
occupational, household, and recreational activity. In-
tensities of activity were categorized as light (nonsedentary
time, 3 METs), moderate (3-5.9 METs) and vigorous ($ 6
METs). Sedentary behavior was defined as occupational
activity with assigned METs # 1.5.
Cox proportional hazards models were used to compute
hazard ratios (HRs) for the primary outcomes of (1)
disease-free survival, defined as the time to first endo-
metrial cancer recurrence/progression or any death, and
(2) overall survival, defined as the time to death from any
cause. Sample size was predetermined on the basis of the
availability of cases from our previous case-control study of
endometrial cancer risk.11 Missing values for covariates,
such as smoking, alcohol, and body mass index (BMI;
, 3% missing) were replaced by the majority reference
group for categorical variables and mean value imputation
for continuous variables. We evaluated the proportional haz-
ards assumption by including an interaction term between
each physical activity variable and follow-up time. Wald tests
were used to select variables for inclusion in Cox proportional
hazards models, except for known prognostic variables (age at
diagnosis, cancer stage, cancer grade, and primary treatment)
which were forced into the model. Women with unknown or
nonapplicable cancer grade were grouped as a separate
category for adjustment. For postdiagnosis physical activity,
we adjusted for time to first new primary cancer as a time-
dependent covariate in the analysis of disease-free survival
and time to first endometrial cancer recurrence, progression,
or new primary cancer in the analysis of overall survival.
We conducted the analysis on pre- and postdiagnosis
physical activity based on the overall MET-hour/week/year
spent in each of the physical activity domains (total, rec-
reational, occupational, and household) and intensities
(nonsedentary total, light, and moderate-to-vigorous
physical activity), as well as occupational sedentary be-
havior. We also assessed interactions between physical
activity and age and BMI (at diagnosis and postdiagnosis)
as continuous variables by entering their cross-products
into multivariable Cox proportional hazards models. The
effect of physical activity change pattern from pre- to
postdiagnosis on survival outcomes was evaluated by di-
viding the study population into four subgroups on the basis
of participation in low or high amounts of physical activity
pre- and postdiagnosis. We used a common median split
point for both physical activity assessments, which for
recreational physical activity was 10 MET-hours/week/year.
Sensitivity analyses excluded women with incomplete
cancer stage or assigned a cancer stage category. All tests
for statistical significance were based on two-sided Wald
tests. Analyses were performed using SAS version 9.4 (SAS
Institute, Cary, NC) and R version 3.6.19
RESULTS
At baseline, participants’ median age was 58 years, BMI
was 31.0 kg/m2, and . 75% were married, White, post-
menopausal, and nonsmokers or ex-smokers. Most par-
ticipants were diagnosed with stage I endometrial cancer
($ 80%) and had undergone a hysterectomy (97%), with
31% also receiving radiation therapy (Table 1). Compared
with participants, nonparticipants were older, had more
comorbidities, higher stages and grades of endometrial cancer
at baseline, received more chemotherapy treatment, and
experienced worse survival outcomes (Appendix Table A1,
online only). During the median follow-up of 14.5 years,
there were 60 deaths (endometrial cancer–specific deaths
[n 5 18]; other deaths [n 5 42]). A total of 80 unique
disease-free survival events occurred (endometrial cancer
recurrences [n 5 20], disease progression recurrence/
disease progression followed by death [n5 22], and deaths
[n 5 38]).
Prediagnosis Physical Activity and Survival
There was no dose-response relationship between in-
creasing total prediagnosis (ie, lifetime physical activity)
and survival outcomes; Table 2. Physical activity performed
at higher levels (. 127 MET-hour/week/year) was not
associated with disease-free survival or overall survival
compared with the lowest tertile of physical activity (# 104
MET-hour/week/year). However, compared with women in
the lowest tertile, those in the middle tertile for lifetime total
physical activity (. 104 to # 127 MET-hour/week/year)
had an HR or 0.41 (95% CI, 0.20 to 0.85) for overall
survival.
When examining survival outcomes by domains of pre-
diagnosis physical activity, we observed a statistically sig-
nificant improvement (HR, 0.44; 95% CI, 0.22 to 0.90) in
overall survival in the middle tertile (. 8 to# 14 MET-hour/
week/year) versus the lowest tertile (# 8 MET-hour/week/
year) for recreational physical activity, but not for occu-
pational and household physical activity. Moreover, pre-
diagnosis recreational physical activity was the only domain
associated with improved disease-free survival, for which
a statistically significant dose-response relationship was
also noted (HR, 0.54; 95% CI, 0.30 to 0.96; Ptrend 5 .04).
Stratification by BMI modified the association for pre-
diagnosis recreational physical activity with overall survival
(Pinteraction 5 .04). Specifically, participants with a BMI of
30 kg/m2 or greater at baseline had improved overall
survival with increasing amounts of recreational physical
activity (Ptrend 5 .013). HR for the highest versus lowest
tertile was 0.30 (95% CI, 0.11 to 0.81), whereas partici-
pants with a BMI less than 30 kg/m2 had an HR of 1.28
(95% CI, 0.45 to 3.64; Appendix Tables A2 and A3, online
only). No statistically significant interactions between
prediagnosis physical activity with baseline age were noted
(results not shown).
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Median age at diagnosis, years (IQR) 58 (54-65) 58 (53-64) 63 (56-71) 65 (58-73)
Highest education
High school diploma 132 (32.0) 108 (30.5) 31 (40.3) 24 (40.7)
Nonuniversity certificate 189 (45.8) 161 (45.5) 36 (46.8) 28 (47.5)
University degree 92 (22.3) 85 (24.0) 10 (13.0) 7 (11.9)
Married or common in-law 396 (93.2) 339 (92.9) 75 (93.8) 57 (95.0)
White 407 (96.7) 347 (96.1) 76 (95.0) 60 (100.0)
Median age at menarche, years (IQR) 12 (11-13) 12 (11-13) 12 (11-13) 12 (11-14)
No. of pregnancies $ 20 weeks gestation
0 75 (18.2) 67 (18.9) 14 (18.2) 8 (13.6)
1-2 179 (43.3) 159 (44.9) 26 (33.8) 20 (33.9)
. 2 159 (38.5) 128 (36.2) 37 (48.1) 31 (52.5)
Median age at menopause, years (IQR) 51 (49-54) 51 (49-54) 50 (47-53) 50 (47-53)
Menopausal status
Pre- and perimenopausal 100 (24.3) 94 (26.4) 13 (16.9) 6 (6.2)
Postmenopausal 312 (75.7) 259 (73.4) 64 (83.1) 53 (89.8)
Overall AJCC stage
I 340 (80.0) 301 (82.5) 46 (57.5) 39 (65.0)
II 55 (12.9) 44 (12.1) 16 (20.0) 11 (18.3)
III 20 (4.7) 13 (3.6) 9 (11.3) 7 (11.7)
IV 4 (0.9) 3 (0.8) 3 (3.8) 1 (1.7)
Incomplete 6 (1.4) 4 (1.1) 6 (7.5) 2 (3.3)
FIGO grade, %
, 6 238 (56.0) 211 (57.8) 36 (45.0) 27 (45.0)
6-50 102 (24.0) 90 (24.7) 16 (20.0) 12 (20.0)
. 50 50 (11.8) 36 (9.9) 18 (22.5) 14 (23.3)
Other 35 (8.2) 28 (7.7) 10 (12.5) 7 (11.7)
Primary treatmenta
Surgery 416 (97.9) 359 (98.4) 72 (90.0) 57 (95.0)
Chemotherapy 28 (6.6) 22 (6.0) 7 (8.8) 6 (10.0)
Hormone therapy 4 (0.9) 4 (1.0) 0 (0.0) 0 (0.0)
Radiation therapy 131 (30.8) 110 (30.1) 28 (35.0) 21 (35.0)
First-degree family history of uterine or colorectal cancer 65 (15.8) 51 (14.5) 17 (21.5) 14 (23.3)
Ever had hormone therapy 141 (34.3) 130 (36.8) 15 (19.7) 11 (19.0)
Ever had myocardial infarctionb 7 (1.7) 5 (1.4) 2 (2.5) 2 (3.3)
Ever had type II diabetesb 50 (11.8) 38 (10.4) 14 (17.5) 12 (20.0)
Ever had angina pectorisb 17 (4.0) 12 (3.3) 5 (6.3) 5 (8.3)
Ever had hypertensionb 129 (31.2) 100 (28.3) 31 (40.3) 29 (49.2)
Ever had pulmonary embolismb 7 (1.7) 4 (1.1) 3 (3.8) 3 (5.1)
Ever had thrombosisb 25 (5.9) 18 (4.9) 8 (10.0) 7 (11.7)
Ever had a strokeb 3 (0.7) 2 (0.6) 1 (1.3) 1 (1.7)
Ever had high cholesterol or triglyceridesb 134 (31.5) 108 (29.6) 34 (42.5) 26 (43.3)
(continued on following page)
4110 © 2020 by American Society of Clinical Oncology Volume 38, Issue 34
Friedenreich et al
Downloaded from ascopubs.org by 152.13.249.80 on April 13, 2021 from 152.013.249.080
Copyright © 2021 American Society of Clinical Oncology. All rights reserved. 
Postdiagnosis Physical Activity and Survival
Participants in the highest tertile for total physical activity
(. 105 MET-hour/week/year) had a nonstatistically sig-
nificant improved overall survival (HR, 0.45; 95% CI, 0.20
to 1.01) and statistically significantly improved disease-free
survival (HR, 0.36; 95% CI, 0.18 to 0.70) compared with
those in the lowest physical activity level tertile (# 64 MET-
hour/week/year; Table 3). In addition, there was a statisti-
cally significant dose-response with increasing tertiles of
total physical activity and improved overall and disease-free
survival for multivariable-adjusted models (Ptrend 5 .05
and .002, respectively).
The highest (. 13 MET-hour/week/year) versus lowest
(# 5 MET-hour/week/year) tertile of postdiagnosis recrea-
tional physical activity participation was strongly associated
with disease-free and overall survival in multivariable-adjusted
models (HR, 0.33; 95% CI, 0.17 to 0.64; and HR, 0.33;
95% CI, 0.15 to 0.75, respectively). Results from Kaplan-
Meier analyses also support statistically significant im-
provements in disease-free survival (Fig 1A; P, .001) and
overall survival (Fig 1B; P , .001) for women who par-
ticipated in the highest amounts of recreational physical
activity. In addition, improved disease-free survival was
noted for participants in the middle versus lowest tertile for
occupational physical activity (HR, 0.52; 95% CI, 0.29 to
0.92), as well as the highest tertiles compared with the
lowest tertiles for household physical activity participation
(HR, 0.44; 95% CI, 0.24 to 0.83). In multivariable-adjusted
models, there was a dose-response for increasing rec-
reational physical activity with improved overall survival
(Ptrend 5 .007), but not for occupational (Ptrend 5 .17) or
household (Ptrend 5 .12) physical activity.
No statistically significant interactions were found between
postdiagnosis physical activity with postdiagnosis BMI or
age (results not shown). A statistically significant dose-
response relationship indicated increased disease-free
survival for hours/week spent participating in moderate-to-
vigorous intensity recreational physical activity (Ptrend 5 .05;
Appendix Table A4, online only). All other analyses of survival
outcomes with occupational sedentary behavior and pre- or











Nonsmoker 208 (50.4) 178 (50.3) 40 (52.0) 30 (50.9)
Current smoker 56 (13.6) 44 (12.4) 13 (16.9) 12 (20.3)
Ex-smoker 131 (31.7) 115 (32.5) 23 (29.9) 16 (27.1)
Occasional smoker 18 (4.4) 17 (4.8) 1 (1.3) 1 (1.7)
BMI, kg/m2 (IQR) 31.0 (26.0-36.9) 30.9 (25.9-36.1) 31.1 (27.2-37.3) 31.4 (27.2-37.9)
Waist circumference, cm (IQR) 95.5 (83.6-109.0) 95.0 (82.9-107.8) 98.9 (87.0-116.9) 100.0 (85.0-116.9)
Total caloric intake, kcal/day (IQR) 1,481 (1,158-1,876) 1,491 (1,188-1,868) 1,347 (1,059-1,916) 1,333 (1,032-1,982)
Alcohol intake, gram/day/year (IQR) 1.0 (0.3-2.8) 1.1 (0.3-2.9) 0.8 (0.0-2.1) 0.6 (0.0-2.1)
Prediagnosis physical activity, MET-hour/week/year (IQR)
Total physical activity 116.2 (97.9-138.5) 116.9 (98.6-138.5) 111.1 (93.8-141.2) 107.1 (92.1-139.7)
Recreational physical activity 10.6 (6.7-16.8) 10.9 (7.2-16.8) 8.7 (6.1-15.0) 7.7 (5.6-15.0)
Occupational physical activity 43.2 (31.3-59.0) 43.9 (32.6-60.5) 41.0 (24.3-55.8) 39.4 (23.4-50.0)
Household physical activity 56.1 (40.5-73.1) 55.1 (40.2-72.4) 56.8 (40.9-79.7) 58.2 (44.0-79.4)
Postdiagnosis physical activity, MET-hour/week/year (IQR)
Total physical activity 85.2 (54.4-116.9) 90.4 (57.4-120.6) 61.6 (37.3-97.4) 60.8 (39.4-92.3)
Recreational physical activity 8.3 (3.0-16.7) 8.8 (3.5-17.4) 4.7 (2.1-10.6) 4.6 (2.3-10.6)
Occupational physical activity 10.2 (0.0-38.2) 11.6 (0.0-41.9) 2.3 (0.0-25.6) 0.1 (0.0-23.3)
Household physical activity 45.3 (30.3-67.2) 46.5 (31.1-68.4) 35.1 (25.2-57.2) 35.2 (26.0-57.2)
Postdiagnosis BMI (IQR) 31.3 (26.6-37.3) 31.3 (26.7-37.0) 31.6 (27.1-38.5) 31.1 (26.2-38.9)
Postdiagnosis Charlson Comorbidity Score (IQR) 1.0 (0.5-2.0) 1.0 (0.5-2.0) 1.5 (0.5-2.5) 1.8 (1.0-3.0)
NOTE. Data presented as No. (%) unless otherwise indicated.
Abbreviations: AJCC, American Joint Committee on Cancer; BMI, body mass index; DFS, disease-free survival; FIGO, International Federation of
Gynecology and Obstetrics; IQR, interquartile range.
aThe frequencies for treatment are not mutually exclusive as participants could have multiple treatments.
bPrediagnosis medical conditions: diabetes, angina pectoris, high cholesterol, pulmonary embolism, myocardial infarction, hypertension, stroke, and
thrombosis were summarized to a baseline comorbidity score: none, 1 or $ 2.
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postdiagnosis physical activity according to intensity were
nonstatistically significant (results not shown). We con-
ducted sensitivity analyses to determine the effect of in-
cluding individuals for whom cancer stage was incomplete
(n 5 6) and found that the results were unchanged.
Change From Pre- to Postdiagnosis Physical Activity
and Survival
Associations between changes in pre- to postdiagnosis
physical activity with overall and disease-free survival are
reported in Table 4, and the sample size of each of the four
change pattern subgroups are reported in Appendix Table
A5 (online only). Compared with womenwho participated in
low levels of recreational physical activity (, 10 MET-hour/
week/year) before and after diagnosis (unchanged-low),
women who maintained high levels of recreational physical
activity (. 10MET-hour/week/year) frompre- to postdiagnosis
(unchanged-high) had longer disease-free survival (HR, 0.35;
95% CI, 0.18 to 0.69) and overall survival (HR, 0.43; 95% CI,
TABLE 2. Disease-Free Survival and Overall Survival in Relation to Lifetime (prediagnosis) Physical Activity, Alberta Endometrial Cancer Cohort Study,
2002-2019 (N 5 425)
Tertiles of Physical Activity Level














Total physical activity, MET-
hours/week/year
# 104 33/141 1.0 1.0 27/141 1.0 1.0
. 104 to # 127 19/139 0.59 (0.33 to
1.05)
0.57 (0.31 to 1.06) 13/139 0.50 (0.25 to
0.99)
0.41 (0.20 to 0.85)
. 127 28/145 0.80 (0.48 to
1.34)
1.06 (0.61 to 1.85) 20/145 0.70 (0.39 to
1.26)
0.81 (0.43 to 1.50)
P for trend .40 .84 .23 .45
Recreational physical activity,
MET-hours/week/year
# 8 36/141 1.0 1.0 30/141 1.0 1.0
. 8 to # 14 21/139 0.61 (0.36 to
1.06)
0.69 (0.38 to 1.24) 12/139 0.43 (0.22 to
0.84)
0.44 (0.22 to 0.90)
. 14 23/145 0.63 (0.37 to
1.08)
0.54 (0.30 to 0.96) 18/145 0.67 (0.37 to
1.21)
0.56 (0.29 to 1.07)
P for trend .08 .04 .13 .06
Occupational physical activity,
MET-hours/week/year
# 36 34/141 1.0 1.0 28/141 1.0 1.0
. 36 to # 52 24/139 0.92 (0.53 to
1.59)
0.85 (0.47 to 1.56) 18/139 0.90 (0.48 to
1.70)
0.91 (0.46 to 1.77)
. 52 22/145 0.84 (0.47 to
1.49)
1.08 (0.59 to 1.96) 14/145 0.75 (0.38 to
1.50)
0.83 (0.40 to 1.72)
P for trend .55 .84 .43 .62
Household physical activity,
MET-hours/week/year
# 45 25/140 1.0 1.0 16/140 1.0 1.0
. 45 to # 67 21/141 0.68 (0.37 to
1.25)
0.39 (0.20 to 0.77) 18/141 0.85 (0.42 to
1.73)
0.50 (0.23 to 1.07)
. 67 34/144 1.00 (0.56 to
1.79)
0.75 (0.40 to 1.41) 26/144 1.04 (0.52 to
2.08)
0.88 (0.43 to 1.81)
P for trend .82 .76 .81 .92
NOTE.Where disease-free survival and overall survival models were adjusted for age, age3 age, overall cancer stage (I and incomplete/II/III and IV), cancer
grade (# 50%/other/.50% International Federation of Gynecology and Obstetrics score), cancer treatments (surgery, chemotherapy, or radiation therapy),
baseline body mass index, baseline menopausal status, baseline hormone therapy use, first-degree family history of cancer, lifetime (prediagnosis)
comorbidity score, and lifetime (prediagnosis) smoking. Models of each subtype of activities were further adjusted for the other types of activities.
Abbreviations: HR, hazard ratio; MET, metabolic-equivalent task.
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0.20 to 0.94). Kaplan-Meier curves further support these
findings for unadjusted disease-free survival (Fig 2A;
P 5 .005) and overall survival (Fig 2B; P 5 .03). Similar
patterns of association were also noted for total physical activity,
but not presented herein because of the small number of
events noted in each physical activity level change category.
DISCUSSION
Women who were diagnosed with endometrial cancer and
reported participating in higher amounts of recreational
physical activity prediagnosis had a 46% lower risk of
cancer recurrence or death. Postdiagnosis total physical
TABLE 3. Disease-Free Survival and Overall Survival in Relation to Postdiagnosis Physical Activity, Alberta Endometrial Cancer Cohort Study,
2002-2019 (N 5 425)
Tertiles of Physical Activity Level















Total physical activity, MET-
hours/week/year
# 64 42/140 1.0 1.0 33/140 1.0 1.0
. 64 to # 105 22/141 0.48 (0.29 to 0.80) 0.58 (0.33 to
1.01)
17/141 0.48 (0.27 to 0.86) 0.73 (0.39 to
1.39)
. 105 16/144 0.38 (0.21 to 0.68) 0.36 (0.18 to
0.70)
10/144 0.34 (0.16 to 0.70) 0.45 (0.20 to
1.01)
P for trend , .001 .002 .001 .05
Recreational physical activity,
MET- hours/week/year
# 5 40/141 1.0 1.0 30/141 1.0 1.0
. 5 to # 13 26/139 0.58 (0.35 to 0.96) 0.55 (0.32 to
0.94)
21/139 0.64 (0.36 to 1.14) 0.65 (0.35 to
1.21)
. 13 14/145 0.30 (0.16 to 0.56) 0.33 (0.17 to
0.64)
9/145 0.27 (0.13 to 0.57) 0.33 (0.15 to
0.75)
P for trend , .001 .001 , .001 .007
Occupational physical activity,
MET- hours/week/year
# 1 37/141 1.0 1.0 31/141 1.0 1.0
. 1 to # 25 22/140 0.65 (0.38 to 1.11) 0.52 (0.29 to
0.92)
16/140 0.55 (0.30 to 1.02) 0.53 (0.28 to
1.03)
. 25 21/144 0.74 (0.41 to 1.34) 0.55 (0.29 to
1.03)
13/144 0.66 (0.32 to 1.35) 0.67 (0.31 to
1.42)
P for trend .23 .04 .13 .17
Household physical activity, MET-
hours/week/year
# 35 39/140 1.0 1.0 28/140 1.0 1.0
. 35 to # 56 20/140 0.48 (0.28 to 0.83) 0.46 (0.25 to
0.82)
16/140 0.54 (0.29 to 1.01) 0.45 (0.23 to
0.89)
. 56 21/145 0.44 (0.26 to 0.76) 0.44 (0.24 to
0.83)
16/145 0.46 (0.24 to 0.86) 0.62 (0.29 to
1.32)
P for trend .002 .006 .013 .12
NOTE. The disease free survival model was adjusted for age, age3 age, overall cancer stage (I and incomplete/II/III and IV), cancer grade (# 50%/other/
. 50% International Federation of Gynecology and Obstetrics score), cancer treatments (surgery, chemotherapy, or radiation therapy), postdiagnosis body
mass index, baselinemenopausal status, baseline hormone therapy use, first-degree family history of cancer, postdiagnosis Charlson Comorbidity score, time
to first new primary cancer, and prediagnosis total physical activity. The overall survival model was adjusted for age, age 3 age, overall cancer stage (I and
missing/II/III and IV), cancer grade (# 50%/other/. 50% International Federation of Gynecology and Obstetrics score), cancer treatments (surgery,
chemotherapy, or radiation therapy), postdiagnosis body mass index, baseline menopausal status, baseline hormone replacement therapy use, first-degree
family history of cancer, postdiagnosis Charlson Comorbidity score, time to first any of endometrial cancer recurrence/progression or new primary cancer, and
prediagnosis total physical activity. Models of each subtype of activities were further adjusted for the other types of activities.
Abbreviations: HR, hazard ratio; MET, metabolic-equivalent task.
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activity was associated with a 64% improvement in disease-
free survival, and recreational physical activity was associated
with 67% improvement in both overall and disease-free
survival. Finally, women who sustained high versus low
levels of recreational physical activity from pre- to postdiagnosis
had a 57% increase in overall survival and a 65% increase
in disease-free survival. Our findings suggest a substantial
benefit for survivors of endometrial cancer who are physically
active throughout their lifespan and recreationally active
postdiagnosis.
Relatively few studies have investigated the relationship
between physical activity and endometrial cancer survival,
and findings have been inconsistent.7-10 Using data from
983 women in the Women’s Health Initiative, Arem and
colleagues7 found no survival benefit with higher levels of
prediagnosis physical activity after a median follow-up of
A
Log-rank test statistics (P < .001)
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No. at risk:
FIG 1. Kaplan-Meier curves for (A) disease-free survival (DFS) and (B) overall survival (OS) among survivors of endometrial cancer based on tertile of
postdiagnosis recreational physical activity (metabolic-equivalent task-hours/week/years).
TABLE 4. Physical Activity Change From Prediagnosis to Postdiagnosis on the Basis of Recreational Physical Activity, Alberta Endometrial
Cancer Cohort Study, 2002-2019 (N 5 425)






Unchanged low physical activity 37/139 1,749.2 2.1 1.0
Decreased from high to low 20/95 1,243.0 1.6 0.56 (0.30 to 1.05)
Increased from low to high 8/52 704.9 1.1 0.68 (0.30 to 1.55)
Unchanged high physical activity 15/139 1,970.4 0.8 0.35 (0.18 to 0.69)
P for trend .004
Overall survival
Unchanged low physical activity 28/139 1,903.6 1.5 1.0
Decreased from high to low 14/95 1,331.0 1.1 0.65 (0.31 to 1.36)
Increased from low to high 7/52 725.3 1.0 0.73 (0.30 to 1.78)
Unchanged high physical activity 11/139 1,995.4 0.6 0.43 (0.20 to 0.94)
P for trend .04
Abbreviation: HR, hazard ratio.
aThe high and low physical activity levels were defined as samemedian split point at 10metabolic-equivalent tasks-hours/weeks/years for both
prediagnosis and postdiagnosis. Covariates adjusted were all previous corresponding variables, further adjusted for baseline total physical activity
and postdiagnosis occupational and household physical activity.
bCovariates adjusted were all previously corresponding variables, further adjusted for baseline total physical activity and post-diagnosis
occupational and household physical activity.
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5.2 years and 163 all-cause deaths. Among 875 women in
the National Institutes of Health’s AARP (NIH-AARP) Diet
and Health Study, . 7 hours/week of prediagnosis, rec-
reational, moderate-to-vigorous intensity physical activity
was associated with a statistically significant 43% decrease
in 5-year all-cause mortality, but this association was at-
tenuated after adjusting for BMI.8 Results from our analyses
suggest that BMI may be an important modifier in the
association between prediagnosis recreational activity and
endometrial cancer outcomes as only participants with
a BMI$ 30 kg/m2 at baseline had improved overall survival
with higher amounts of recreational physical activity.
Overall and disease-free survival were higher among
women who participated in more total and recreational
physical activity postdiagnosis. Our findings are supported
by those of a recent observational study that used National
Health Interview Survey–linked mortality files with follow-
up.10 The study found that among 1,038 survivors of en-
dometrial cancer, women who participated in at least
150 minutes/week of moderate-intensity physical activity or
75 minutes/week of vigorous-intensity aerobic physical
activity after diagnosis experienced reductions in all-cause
mortality compared with survivors who engaged in nei-
ther.10 Conversely, in participants from the NIH-AARP
endometrial cancer cohort, postdiagnosis recreational
physical activity performed at moderate-to-vigorous in-
tensity was not statistically significantly associated with all-
cause mortality at any level of MET expenditure.9
To our knowledge, our study is the first to examine how
changes in pre- to postdiagnosis physical activity levels
relate to endometrial cancer survival. Research involving
survivors of breast cancer has shown that maintaining an
inactive lifestyle or decreasing recreational physical activity
from pre- to postdiagnosis may increase all-cause
mortality.20-22 Furthermore, increasing recreational physi-
cal activity may decrease all-cause mortality.23 In female
survivors of colorectal cancer, increasing recreational
physical activity after diagnosis also yielded reductions
in cancer-specific and overall mortality.24 Our findings
revealed that the greatest survival benefits were experi-
enced by women who sustained high levels of recreational
physical activity from pre- to postdiagnosis and highlight the
importance of promoting physical activity throughout the
lifespan as a modifiable risk factor to reduce the incidence
and mortality from endometrial cancer. We observed sur-
vival benefits with . 5 to # 13 MET-hours/week/year of
recreational activity (equivalent to 100-300 minutes/week
of moderate-intensity [3-4.5 MET] activity), a level that is
achievable by most populations and comparable to those
observed in our population controls.11
The mechanisms whereby physical activity alters endo-
metrial cancer risk and prognosis are not fully understood.
Many hypothesized biologic pathways suggest that physical
activity attenuates the risk of dying through its impact on
obesity,25 although our analyses adjusted for BMI suggests
physical activity has an association with survival in-
dependently of obesity. Physical activity may contribute
to reducing the risk of dying from endometrial cancer
by reducing adiposity levels, inflammation, adipokines,
insulin resistance, and endogenous sex hormones.26-28
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FIG 2. Kaplan-Meier curves for (A) disease-free survival (DFS) and (B) overall survival (OS) among survivors of endometrial cancer based on change in
recreational physical activity from pre- to postdiagnosis. The high and low physical activity levels were defined as the samemedian split point at 10metabolic-
equivalent tasks-hours/week/years for both prediagnosis and postdiagnosis.
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Cardiorespiratory fitness, an important predictor of all-
cause mortality and survival in patients with cancer, is
reduced in women with gynecologic cancers compared
with healthy controls.29,30 Therefore, postdiagnosis physical
activity participation may be particularly important for im-
proving cardiorespiratory fitness, decreasing obesity and
inflammation, and improving insulin resistance, and
through these mechanisms, enhancing survival outcomes
in survivors of endometrial cancer.
Despite the increasing evidence that physical activity im-
proves cancer outcomes,31 more than one half of survivors
of cancer are physically inactive.32-34 Consequently, nu-
merous agencies are raising awareness regarding physical
activity benefits for cancer survival.27,35-38 For example, the
Moving Through Cancer exercise prescription developed by
the American College of Sports Medicine helps health care
professionals design and deliver physical activity programs
for patients with cancer and survivors, with the ultimate goal
of improving patient-reported outcomes and survival.38 Our
study provides needed data on the domain, dose, and
timing of physical activity that may maximize survival
outcomes for survivors of endometrial cancer.
The strengths of our study include the population-based
sampling from across Alberta, detailed physical activity
data, comprehensive assessment of covariates, direct
anthropometry measures, comprehensive outcome as-
sessments captured by specialized professionals, and
a long follow-up period to observe endometrial cancer
outcomes, which has a high survival rate (83%). Limitations
include a small cohort with modest number of events,
which decreased statistical power to detect dose-response
associations, a lack of objective measures of physical ac-
tivity or fitness, a single measure of physical activity at one
time point pre- and postdiagnosis, lack of specific cause of
death other than for endometrial cancer, a relatively ho-
mogeneous White population, and possible Type I error
because of multiple comparisons.
In conclusion, the findings from our study support
emerging evidence that lifetime physical activity, as well as
postdiagnosis recreational physical activity, are associated
with improved survival outcomes among survivors of en-
dometrial cancer. Although maintaining high levels of
physical activity from pre- to postdiagnosis is most bene-
ficial for improving survival, physical activity after an en-
dometrial cancer diagnosis is more strongly associated with
improved survival than prediagnosis physical activity. Fu-
ture observational research investigating the relationship
between physical activity and endometrial cancer survival
should use objective measures of physical activity and
examine the effects of health-related fitness on survival.
Clinical trials involving an exercise intervention with long-
term follow-up for survival outcomes are also warranted;
however, such trials would be challenging given the high
survival rate in this group.
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FIG A1. Flowchart of study participants in the Alberta Endometrial Cancer Cohort Study, 2002-2019.
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Deatha 60 (14.1) 51 (44.0)
Recurrence/progressiona 42 (9.9) 31 (26.7)
Median age at diagnosis, years (IQR) 58 (54-65) 61 (53-67)
Highest education
High school diploma 132 (32.0) 39 (36.1)
Nonuniversity certificate 189 (45.8) 49 (45.4)
University degree 92 (22.3) 20 (18.5)
Married or common in-law 396 (93.2) 104 (90.0)
Whitea 407 (96.7) 101 (88.6)
Median age at menarche, years (IQR)a 12 (11-13) 13 (12-14)
No. of pregnancies $ 20 weeks gestation
0 75 (18.2) 19 (17.6)
1-2 179 (43.3) 43 (39.8)
. 2 159 (38.5) 46 (42.6)
Median age at menopause, years (IQR) 51 (49-54) 50 (47-53)
Menopausal status
Pre- and perimenopausal 100 (24.3) 21 (19.4)
Postmenopausal 312 (75.7) 87 (81.6)
Overall AJCC stagea
I 340 (80.0) 81 (70.0)
II 55 (12.9) 14 (12.1)
III 20 (4.7) 14 (12.1)
IV 4 (0.9) 5 (4.3)
Missing 6 (1.4) 2 (1.7)
FIGO gradea, %
, 6 238 (56.0) 49 (42.2)
6-50 102 (24.0) 23 (19.8)
. 50 50 (11.8) 24 (20.7)
Other 35 (8.2) 20 (17.2)
Primary treatment
Surgery 416 (97.9) 112 (96.6)
Chemotherapya 28 (6.6) 15 (12.9)
Hormone therapy 4 (0.9) 0 (0.0)
Radiation therapy 131 (30.8) 35 (30.2)
First-degree family history of uterus or colorectal cancer 65 (15.8) 23 (19.8)
Ever hormone therapy use 141 (34.3) 38 (35.2)
Comorbidityb
None 252 (61.0) 54 (50.0)
1 139 (33.7) 45 (41.7)
$ 2 22 (5.3) 9 (8.3)
(continued on following page)
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Nonsmoker 208 (50.4) 57 (52.8)
Current smoker 56 (13.6) 13 (12.0)
Ex-smoker 131 (31.7) 34 (31.5)
Occasional smoker 18 (4.4) 4 (3.7)
BMI, kg/m2 (IQR) 31.0 (26.0-36.9) 31.1 (27.3-37.5)
Waist circumference, cm (IQR) 95.5 (83.6-109.0) 95.9 (88.0-110.0)
Total caloric intake, kcal/day (IQR) 1,481 (1,158-1,876) 1,487 (1,108-1,906)
Daily alcohol intake, gram/day (IQR) 1.0 (0.3-2.8) 0.8 (0.0-3.1)
Prediagnosis physical activity, MET-hour/week (IQR)
Total physical activity 116.2 (97.9-138.5) 116.5 (93.0-134.9)
Recreational physical activity 10.6 (6.7-16.8) 10.8 (7.4-16.9)
Occupational physical activity 43.2 (31.3-59.0) 42.9 (23.8-63.6)
Household physical activity 56.1 (40.5-73.1) 56.6 (40.7-79.3)
NOTE. Data presented as No. (%) unless otherwise indicated.
Abbreviations: AJCC, American Joint Committee on Cancer; BMI, body mass index; FIGO, International Federation of Gynecology and
Obstetrics; IQR, interquartile range.
aSignificantly different at P 5 .05.
bPrediagnosis medical conditions: diabetes, angina pectoris, high cholesterol, pulmonary embolism, myocardial infarction, hypertension,
stroke, and thrombosis were summarized to a baseline comorbidity score: none, 1 or $ 2.
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TABLE A2. Disease-Free Survival in Relation to Lifetime (prediagnosis) Physical Activity Stratified by Baseline BMI, Alberta Endometrial Cancer Cohort Study,
2002-2019 (N 5 425)
























# 106 14/63 1.0 # 102 18/76 1.0 .56
. 106 to # 127 7/64 0.41 (0.13 to 1.27) . 102 to # 127 13/77 0.70 (0.32 to 1.52)
. 127 10/65 1.03 (0.37 to 2.91) . 127 18/80 1.18 (0.57 to 2.44)






# 9 10/64 1.0 # 7 24/77 1.0 .86
. 9 to # 16 8/62 0.69 (0.22 to 2.11) . 7 to # 13 13/77 0.58 (0.27 to 1.24)
. 16 13/66 1.02 (0.39 to 2.69) . 13 12/79 0.46 (0.21 to 1.02)






# 33 14/63 1.0 # 38 19/77 1.0 .53
. 33 to # 51 10/63 5.41 (1.35 to 21.7) . 38 to # 55 15/77 0.67 (0.31 to 1.47)
. 51 7/66 2.46 (0.67 to 9.01) . 55 15/79 1.09 (0.51 to 2.30)






# 46 11/63 1.0 # 44 13/76 1.0 .36
. 46 to # 68 7/63 0.40 (0.12 to 1.29) . 44 to # 66 15/78 0.61 (0.25 to 1.48)
. 68 13/66 0.49 (0.16 to 1.50) . 66 21/79 1.00 (0.43 to 2.31)
P for trend .28 .69
NOTE.Where disease-free survival and overall survival models were adjusted for age, age3 age, overall cancer stage (I and incomplete/II/III and IV), cancer
grade (# 50%/other/. 50% International Federation of Gynecology and Obstetrics score), cancer treatments (surgery, chemotherapy, or radiation therapy),
baseline menopausal status, baseline hormone therapy use, first-degree family history of cancer, lifetime (prediagnosis) comorbidity score, and lifetime
(prediagnosis) smoking. Models of each subtype of activities were further adjusted for the other types of activities.
Abbreviations: BMI, body mass index; HR, hazard ratio; MET, metabolic-equivalent task.
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TABLE A3. Overall Survival in Relation to Lifetime (prediagnosis) Physical Activity Stratified by Baseline BMI, Alberta Endometrial Cancer Cohort Study,
2002-2019 (N 5 425)
























# 106 10/63 1.0 # 102 16/76 1.0 .44
. 106 to # 127 5/64 0.35 (0.09 to 1.36) . 102 to # 127 9/77 0.45 (0.19 to 1.07)
. 127 7/65 0.94 (0.29 to 3.00) . 127 13/80 0.72 (0.33 to 1.57)






# 9 8/64 1.0 # 7 20/77 1.0 .04
. 9 to # 16 4/62 0.42 (0.11 to 1.54) . 7 to # 13 10/77 0.56 (0.24 to 1.30)
. 16 10/66 1.28 (0.45 to 3.64) . 13 8/79 0.30 (0.11 to 0.81)






# 33 11/63 1.0 # 38 16/77 1.0 .78
. 33 to # 51 7/63 4.49 (0.92 to 21.9) . 38 to # 55 12/77 0.78 (0.34 to 1.80)
. 51 4/66 2.12 (0.47 to 9.64) . 55 10/79 0.83 (0.35 to 1.98)






# 46 6/63 1.0 # 44 9/76 1.0 .74
. 46 to # 68 6/63 0.36 (0.10 to 1.37) . 44 to # 66 13/78 0.67 (0.24 to 1.83)
. 68 10/66 0.53 (0.15 to 1.91) . 66 16/79 1.08 (0.42 to 2.81)
P for trend 0.40 .61
NOTE.Where disease-free survival and overall survival models were adjusted for age, age3 age, overall cancer stage (I and incomplete/II/III and IV), cancer
grade (# 50%/other/.50% International Federation of Gynecology and Obstetrics score), cancer treatments (surgery, chemotherapy, or radiation therapy),
baseline menopausal status, baseline hormone therapy use, first-degree family history of cancer, lifetime (prediagnosis) comorbidity score, and lifetime
(prediagnosis) smoking. Models of each subtype of activities were further adjusted for the other types of activities.
Abbreviations: BMI, body mass index; HR, hazard ratio; MET, metabolic-equivalent task.
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TABLE A4. Disease-Free Survival and Overall Survival in Relation to Postdiagnosis Occupational Sedentary Behavior and Physical Activity by Different
Intensities, Alberta Endometrial Cancer Cohort Study (N 5 425)
Tertiles of Physical
Activity Level










Total physical activity, hour/week/year
# 22 41/140 1.0 32/140 1.0
. 22 to # 34 22/141 0.80 (0.39 to 1.67) 18/141 1.21 (0.51 to 2.89)
. 34 17/144 0.76 (0.22 to 2.63) 10/144 1.60 (0.35 to 7.26)
P for trend .62 .55
Occupational sedentary behavior,
hour/week/year
# 1 38/141 1.0 30/141 1.0
. 1 to # 12 22/139 0.61 (0.35 to 1.05) 18/139 0.73 (0.39 to 1.37)
. 12 20/145 0.59 (0.29 to 1.22) 12/145 0.65 (0.28 to 1.54)
P for trend .07 .24
Total light physical activity: MET , 3.0,
hour/week/year
# 14 33/140 1.0 25/140 1.0
. 14 to # 21 27/141 0.65 (0.37 to 1.16) 22/141 0.62 (0.32 to 1.20)
. 21 20/144 0.68 (0.33 to 1.41) 13/144 0.58 (0.24 to 1.40)
P for trend .23 .18
Total MVPA physical activity: MET $ 3.0,
hour/week/year
# 3 44/141 1.0 34/141 1.0
. 3 to # 12 18/140 0.57 (0.31 to 1.06) 14/140 0.64 (0.31 to 1.31)
. 12 18/144 0.70 (0.32 to 1.54) 12/144 1.22 (0.47 to 3.19)
P for trend .21 .95
Recreational MVPA physical activity: MET$ 3.0,
hour/week/year
# 1 40/140 1.0 32/140 1.0
. 1 to # 3 23/141 0.63 (0.35 to 1.11) 17/141 0.71 (0.37 to 1.37)
. 3 17/144 0.54 (0.28 to 1.04) 12/144 0.47 (0.21 to 1.06)
P for trend .05 .06
NOTE. Where disease free survival model was adjusted for age, age3 age, overall cancer stage (I and incomplete/II/III and IV), cancer grade (# 50%/other/
.50% International Federation of Gynecology and Obstetrics score), cancer treatments (surgery, chemotherapy, or radiation therapy), postdiagnosis body
mass index, baselinemenopausal status, baseline hormone therapy use, first-degree family history of cancer, postdiagnosis Charlson Comorbidity score, time
to first new primary cancer, prediagnosis total physical activity, and postdiagnosis total physical activity in MET-hours/week/year. Overall survival model was
adjusted for age, age3 age, overall cancer stage (I and missing/II/III and IV), cancer grade (# 50%/other/. 50% International Federation of Gynecology and
Obstetrics score), cancer treatments (surgery, chemotherapy, or radiation therapy), postdiagnosis body mass index, baseline menopausal status, baseline
hormone therapy use, first-degree family history of cancer, postdiagnosis Charlson Comorbidity score, time to first of endometrial cancer recurrence/
progression or new primary cancer, prediagnosis total physical activity, and postdiagnosis total physical activity in MET-hours/week/year.
Abbreviations: DFS, disease-free survival; HR, hazard ratio; MET, metabolic-equivalent task; MVPA, moderate-to-vigorous physical activity.
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TABLE A5. Sample Size for Patterns of Recreational Physical Activity Change From





< 10 ‡ 10 Total
, 10 139a 52c 191
$ 10 95b 139d 234
Total 234a 191a 425
NOTE. Values represent the number of survivors of endometrial cancer in each
pattern of pre- and postdiagnosis physical activity.
aSubgroup of women who were unchanged low.
bSubgroup of women who decreased.
cSubgroup of women who increased.
dSubgroup of women unchanged high.
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